Recurrent Grade 3a Follicular Lymphoma
11 clinical trials · Condition
◉ Watch Recurrent Grade 3a Follicular Lymphoma
| Record | Firm | Date |
|---|---|---|
| CpG-STAT3 siRNA CAS3/SS3 and Localized Radiation Therapy for the Treatment of Relapsed/Refractory B-Cell NHL (NCT04995536) | City of Hope Medical Center | 2021-07-27 |
| Nivolumab for Relapsed, Refractory, or Detectable Disease Post Chimeric Antigen Receptor T-cell Treatment in Patients With Hematologic Malignancies (NCT04205409) | University of Washington | 2020-06-05 |
| Pembrolizumab and Vorinostat in Patients With Relapsed or Refractory DLBCL, FCL or HL. (NCT03150329) | City of Hope Medical Center | 2017-07-18 |
| Lenalidomide and Blinatumomab for the Treatment of Relapsed Non-Hodgkin Lymphoma (NCT02568553) | National Cancer Institute (NCI) | 2016-11-15 |
| Rituximab and Pembrolizumab With or Without Lenalidomide in Treating Patients With Relapsed Follicular Lymphoma and Diffuse Large B-Cell Lymphoma (NCT02446457) | M.D. Anderson Cancer Center | 2015-07-31 |
Track Recurrent Grade 3a Follicular Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.